The inflammatory process, stimulated by reperfusion following tissue ischemia, leads to local injury. With sufficiently large regions and times of ischemia, sizable quantities of mediators gain entry into the vasculature and lead to remote organ failure accompanied by prominent leukosequestration. This study of reperfusion injury will test the postulates that; (1) in the ischemic region, endothelial phenotype changes with the appearance of neoantigens, causing the deposition of immune complexes and activation of the classical complement pathway; (2) local injury via the terminal C5b-9 complex is permitted by loss of membrane complement regulatory proteins as well as the appearance of a scaffolding to strengthen complement binding to the cell membrane; (3) the scaffolding is thought to be provided by the adhesion glycoprotein P selectin which contains 9 short consensus repeats homologous with other complement binding proteins; (4) remote pulmonary injury is dependent upon binding of C3 components to an altered endothelium. This complement fragment works in synergy with neutrophils. Reoxygenation and reperfusion experiments will be conducted in endothelial cell cultures, ex-vivo blood vessels as well as in intact mice, rats, human volunteers, patients undergoing thoracoabdominal aneurysmectomy and femoral-popliteal bypass surgery. Assays will include the detection of membrane bound immune complexes, complement fragments, complement regulatory proteins as well as cell bound and soluble P-selectin. A variety of reagents will be employed to study mechanisms of injury, including monoclonal antibodies to proteins as well as genetically engineered materials: peptides homologous with selectin complementarily determining regions; soluble P-selectin, soluble counter receptor of P-selectin including sialyl Lewis and P-selectin glycoprotein ligand-1. Measurement techniques include immunohistochemistry, flow cytometry as well as standard methods for muscle and lung permeability using 125I-albumin, myeloperoxidase for neutrophil sequestration and the hemolytic red cell assay for classical and alternative complement activation. The data generated should provide an understanding of the putative functions of P selectin in leukocyte-endothelial adhesion as well as in complement binding.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center (P50)
Project #
1P50GM052585-03
Application #
6240630
Study Section
Project Start
1997-04-01
Project End
1998-03-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Sadeghipour, Hamed; Torabi, Radbeh; Gottschall, James et al. (2017) Blockade of IgM-Mediated Inflammation Alters Wound Progression in a Swine Model of Partial-Thickness Burn. J Burn Care Res 38:148-160
Sheu, Eric G; Wakatsuki, Kohei; Oakes, Sean et al. (2016) Prevention of intestinal ischemia-reperfusion injury in humanized mice. Surgery 160:436-42
Bankova, L G; Dwyer, D F; Liu, A Y et al. (2015) Maturation of mast cell progenitors to mucosal mast cells during allergic pulmonary inflammation in mice. Mucosal Immunol 8:596-606
Dwyer, Daniel F; Woodruff, Matthew C; Carroll, Michael C et al. (2014) B cells regulate CD4+ T cell responses to papain following B cell receptor-independent papain uptake. J Immunol 193:529-39
Bankova, Lora G; Lezcano, Cecilia; Pejler, Gunnar et al. (2014) Mouse mast cell proteases 4 and 5 mediate epidermal injury through disruption of tight junctions. J Immunol 192:2812-20
Houde, Martin; Jamain, Marc-David; Labonte, Julie et al. (2013) Pivotal role of mouse mast cell protease 4 in the conversion and pressor properties of Big-endothelin-1. J Pharmacol Exp Ther 346:31-7
Gurish, Michael F; Austen, K Frank (2012) Developmental origin and functional specialization of mast cell subsets. Immunity 37:25-33
Younan, George J; Heit, Yvonne I; Dastouri, Pouya et al. (2011) Mast cells are required in the proliferation and remodeling phases of microdeformational wound therapy. Plast Reconstr Surg 128:649e-58e
Afnan, Jalil; Ahmadi-Yazdi, Cyrus; Sheu, Eric G et al. (2010) Inhibition of rat gut reperfusion injury with an agent developed for the mouse. Evidence that amplification of injury by innate immunity is conserved between two animal species. Am J Physiol Regul Integr Comp Physiol 298:R1675-81
Haas, Michael S; Alicot, Elisabeth M; Schuerpf, Franziska et al. (2010) Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction. Cardiovasc Res 87:618-27

Showing the most recent 10 out of 34 publications